1. Home
  2. MNOV vs AIRG Comparison

MNOV vs AIRG Comparison

Compare MNOV & AIRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNOV
  • AIRG
  • Stock Information
  • Founded
  • MNOV 2000
  • AIRG 1995
  • Country
  • MNOV United States
  • AIRG United States
  • Employees
  • MNOV N/A
  • AIRG N/A
  • Industry
  • MNOV Biotechnology: Pharmaceutical Preparations
  • AIRG Radio And Television Broadcasting And Communications Equipment
  • Sector
  • MNOV Health Care
  • AIRG Technology
  • Exchange
  • MNOV Nasdaq
  • AIRG Nasdaq
  • Market Cap
  • MNOV 89.8M
  • AIRG 79.4M
  • IPO Year
  • MNOV 2005
  • AIRG 2016
  • Fundamental
  • Price
  • MNOV $1.90
  • AIRG $7.24
  • Analyst Decision
  • MNOV Strong Buy
  • AIRG Strong Buy
  • Analyst Count
  • MNOV 1
  • AIRG 2
  • Target Price
  • MNOV $9.00
  • AIRG $11.75
  • AVG Volume (30 Days)
  • MNOV 20.7K
  • AIRG 36.1K
  • Earning Date
  • MNOV 02-13-2025
  • AIRG 02-27-2025
  • Dividend Yield
  • MNOV N/A
  • AIRG N/A
  • EPS Growth
  • MNOV N/A
  • AIRG N/A
  • EPS
  • MNOV N/A
  • AIRG N/A
  • Revenue
  • MNOV N/A
  • AIRG $55,586,000.00
  • Revenue This Year
  • MNOV N/A
  • AIRG $14.12
  • Revenue Next Year
  • MNOV N/A
  • AIRG $15.47
  • P/E Ratio
  • MNOV N/A
  • AIRG N/A
  • Revenue Growth
  • MNOV N/A
  • AIRG N/A
  • 52 Week Low
  • MNOV $1.12
  • AIRG $3.71
  • 52 Week High
  • MNOV $2.55
  • AIRG $10.34
  • Technical
  • Relative Strength Index (RSI)
  • MNOV 45.15
  • AIRG 42.99
  • Support Level
  • MNOV $1.87
  • AIRG $5.90
  • Resistance Level
  • MNOV $2.06
  • AIRG $7.59
  • Average True Range (ATR)
  • MNOV 0.08
  • AIRG 0.53
  • MACD
  • MNOV 0.00
  • AIRG 0.00
  • Stochastic Oscillator
  • MNOV 47.48
  • AIRG 37.74

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

About AIRG Airgain Inc.

Airgain Inc is engaged in providing antenna technologies. These technologies can be used to enable performance wireless networking across devices and markets which include connected homes, enterprises, automotive, and the Internet of Things. It also provides solutions to complex radio frequency, engineering challenges, and improving wireless service that require higher throughput, broad coverage footprint, and carrier-grade quality. Geographically, it derives maximum revenue from North America and also has a presence in China and the Rest of the World. The company products include Antenna Plus: Fleet, M2M, IoT Antennas, Carrier-Class Antenna, Embedded Antennas, and External Dipole Antennas.

Share on Social Networks: